Weight Loss for Prediabetes: How Much Can Help Blood Sugar Return to Normal?

For many people with prediabetes, losing 5–7% of body weight can help blood sugar return to the normal range and lower the chance of type 2 diabetes. The Diabetes Prevention Program found this weight-loss target, paired with activity, cut diabetes progression by 58% over about 3 years [1].

What is prediabetes, and why does weight matter?

Prediabetes means blood sugar is above the normal range but below the level used to diagnose type 2 diabetes. Common lab cutoffs include A1C of 5.7% to 6.4%, fasting plasma glucose of 100 to 125 mg/dL, or a 2-hour oral glucose tolerance test result of 140 to 199 mg/dL [3].

Weight matters because extra visceral adipose tissue, the fat stored around organs, is linked with insulin resistance. Insulin resistance means the body needs more insulin to move glucose from the blood into cells [2,3].

Not everyone with prediabetes has the same body size or the same risk. Age, family history, pregnancy-related diabetes, sleep, medicines, and ethnicity can all affect risk, so lab testing and clinician review are important [3].

How much weight do you need to lose to improve prediabetes?

The 5–7% target from the Diabetes Prevention Program

The best-known target comes from the Diabetes Prevention Program, a large clinical trial in adults at high risk for type 2 diabetes. The lifestyle group aimed for at least 7% weight loss and 150 minutes of moderate physical activity each week; this reduced progression to type 2 diabetes by 58% compared with placebo over an average 2.8 years [1].

A 5–7% loss is often a practical first target because it is large enough to change metabolism but small enough to be realistic for many people. For example, 5–7% is 10–14 pounds for someone starting at 200 pounds. Individual results vary, and blood sugar must be checked with labs [1,3].

What happens at 10% or more

More weight loss may lead to larger metabolic changes for some people. In long-term follow-up of the Diabetes Prevention Program, lifestyle changes continued to lower diabetes development compared with placebo, though the size of the benefit changed over time [4].

Larger weight loss can also bring trade-offs. Rapid or major weight loss may increase the risk of gallbladder symptoms, muscle loss if protein and resistance training are too low, and medication dose changes for people taking blood pressure or glucose-lowering drugs [8,9,10].

How does losing weight improve blood sugar?

Insulin sensitivity and visceral fat

Weight loss can improve insulin sensitivity by reducing fat in and around organs, including visceral adipose tissue. In the Diabetes Prevention Program, weight loss was the strongest predictor of lower diabetes risk: each kilogram of weight loss was linked with about a 16% lower risk of developing diabetes during the trial [2].

This does not mean weight is the only factor. Sleep, stress, activity, food quality, genetics, and some medications can all affect insulin resistance and fasting glucose [3].

A1C and fasting glucose changes

A1C, also called HbA1c, estimates average blood sugar over about 2 to 3 months. Fasting plasma glucose measures blood sugar after not eating. An oral glucose tolerance test checks how the body handles a glucose drink over 2 hours [3].

Because A1C changes slowly, a person may not see the full lab effect of weight loss right away. Clinicians often recheck labs after a few months, but the right timing depends on the person’s baseline labs, medicines, and risk factors [3].

What diet works best for prediabetes weight loss?

Mediterranean and low-carb patterns

There is no single best diet for every person with prediabetes. The strongest plan is usually the one that helps you keep a calorie deficit, eat enough protein and fiber, and maintain it over time. Mediterranean-style and lower-carbohydrate eating patterns have both been studied for cardiometabolic health [5,6].

A Mediterranean diet usually emphasizes vegetables, beans, fruit, whole grains, fish, olive oil, nuts, and less refined starch and processed meat. In the PREDIMED trial, a Mediterranean diet pattern lowered major cardiovascular events in high-risk adults, though that trial was not designed as a prediabetes weight-loss program [5].

Lower-carbohydrate diets may improve blood sugar for some people by reducing glucose spikes and lowering overall calories. They can be harder to sustain for some people, and people taking glucose-lowering medicines need clinician guidance because medication-related low blood sugar can occur with some diabetes drugs [6].

Practical food swaps

• Swap sugar-sweetened drinks for water, seltzer, or unsweetened tea.
• Build meals around lean protein, high-fiber carbohydrates, and non-starchy vegetables.
• Choose beans, lentils, oats, berries, and whole grains more often than refined starches.
• Use olive oil, nuts, avocado, or fish for unsaturated fats, while watching portions.
• Plan protein at breakfast to reduce hunger later in the day.

Food changes can lower glucose, but they can also expose problems like disordered eating, overly restrictive dieting, or fatigue from under-eating. If a plan feels extreme or hard to follow, it is worth adjusting with a clinician or dietitian [3,6].

How much exercise do you need?

The 150-minutes-per-week benchmark

The Diabetes Prevention Program used a goal of 150 minutes per week of moderate activity, such as brisk walking. This was paired with dietary change and weight loss, so the benefit came from the whole lifestyle program, not exercise alone [1].

A simple starting point is to reduce long sitting periods and add walking after meals when safe. People with chest pain, severe shortness of breath, foot ulcers, advanced neuropathy, or major heart disease should get medical guidance before changing activity [7].

Resistance training for insulin sensitivity

Resistance training helps preserve muscle during weight loss. Muscle is one of the main places the body stores and uses glucose, so keeping muscle can support insulin sensitivity [7].

Exercise can cause soreness, injury, or low blood sugar in people using certain glucose-lowering medicines. A clinician can help adjust the plan if you have joint pain, heart disease, neuropathy, or balance problems [7].

When should you consider medication?

Medication may be considered when prediabetes risk is high, when lifestyle change has not moved labs enough, or when weight-related health conditions are present. Any medication choice should weigh benefits, side effects, contraindications, cost, pregnancy plans, and lab results [3].

Metformin

Metformin is FDA-approved for type 2 diabetes, not specifically for prediabetes, but it has been studied for diabetes prevention. In the Diabetes Prevention Program, metformin reduced progression to type 2 diabetes by 31% compared with placebo over an average 2.8 years, with stronger effects in some higher-risk groups [1,4].

Metformin can cause nausea, diarrhea, abdominal discomfort, and vitamin B12 deficiency with long-term use. It may not be appropriate for some people with significant kidney disease or other risk factors for lactic acidosis, so kidney function and medical history matter [3].

GLP-1 receptor agonists: semaglutide

Wegovy and Ozempic are brand names for semaglutide, a GLP-1 receptor agonist; semaglutide may also be available as a compounded formulation through licensed 503A pharmacies. Wegovy is FDA-approved for chronic weight management and cardiovascular risk reduction in certain adults, while Ozempic is FDA-approved for type 2 diabetes and related cardiovascular risk reduction, not specifically for prediabetes [8,9].

In the STEP 1 trial, adults with overweight or obesity without diabetes received semaglutide 2.4 mg once weekly plus lifestyle intervention and had greater weight loss than placebo at 68 weeks; individual results varied [8]. Common side effects in semaglutide trials and labeling include nausea, vomiting, diarrhea, constipation, abdominal pain, and possible gallbladder problems, and it is contraindicated in people with a personal or family history of medullary thyroid carcinoma or MEN2 [8,9].

GIP/GLP-1 dual agonists: tirzepatide

Zepbound and Mounjaro are brand names for tirzepatide, a GIP/GLP-1 dual agonist; tirzepatide may also be available as a compounded formulation through licensed 503A pharmacies. Zepbound is FDA-approved for chronic weight management and obstructive sleep apnea in certain adults with obesity, while Mounjaro is FDA-approved for type 2 diabetes, not specifically for prediabetes [10].

In the SURMOUNT-1 trial, adults with obesity or overweight without diabetes received tirzepatide 5 mg, 10 mg, or 15 mg once weekly plus lifestyle intervention and lost more weight than placebo at 72 weeks; individual results varied [10]. Common side effects include nausea, diarrhea, vomiting, constipation, and abdominal pain, and the label includes warnings about gallbladder disease, pancreatitis, kidney injury from dehydration, and a contraindication for personal or family history of medullary thyroid carcinoma or MEN2 [10].

Compounded GLP-1 options

Compounded semaglutide via 503A pharmacy and compounded tirzepatide via 503A pharmacy are prepared for an individual patient based on a prescription. Compounded medications are not FDA-approved products, and the FDA does not review them for safety, effectiveness, or quality before they are dispensed [11].

A state-licensed 503A compounding pharmacy can prepare a medication when legal requirements are met, such as when a prescriber determines a compounded version is appropriate for a specific patient. Patients should ask about pharmacy licensing, sterility testing when relevant, ingredient source, and how side effects are monitored [11].

How can you get evaluated and access treatment?

A good evaluation starts with lab testing and a review of weight history, medications, family history, pregnancy plans, blood pressure, lipids, kidney function, and symptoms. Prediabetes cannot be confirmed or cleared by symptoms alone; it requires A1C, fasting plasma glucose, oral glucose tolerance testing, or a clinician-selected lab plan [3].

Access can happen through a primary-care clinician, endocrinologist, obesity-medicine clinician, registered dietitian, or a licensed telehealth provider. Chia is one telehealth option that offers clinician-reviewed care for eligible adults, including compounded GLP-1 treatment through US 503A pharmacy partners when appropriate.

Before starting any medication, ask how benefits will be measured, what side effects should prompt help, what labs need follow-up, and what happens if your A1C or fasting glucose returns to the normal range. A safe plan should include follow-up, not just a prescription [3,8,9,10].

How long does it take to improve prediabetes?

A1C reflects about 2 to 3 months of average blood sugar, so lab changes often take several months to show clearly. Fasting glucose can change sooner, but it also varies with sleep, illness, stress, food intake, and medications [3].

In the Diabetes Prevention Program, the main results were measured over an average of 2.8 years, but lifestyle habits began early and were supported over time [1]. Long-term follow-up showed that diabetes risk reduction can persist, but ongoing support matters [4].

If your labs return to the normal range, that is a strong sign, but it is not a permanent guarantee. Prediabetes can come back if weight, activity, sleep, medications, or health conditions change, so periodic lab checks remain important [3,4].

Frequently asked questions

Keep reading

Weight Loss Medications

Metformin for Weight Loss: How It Works, How Much to Expect, and Who It’s For

Weight Loss Medications

Metformin Dose for Weight Loss: What the Evidence Actually Shows

Metabolic Health

The Best Diet for Metabolic Syndrome: An Evidence-Based Guide